Vaccines, In Brief: Meningitis B Recommendation Limited To High-Risk Groups
This article was originally published in The Pink Sheet Daily
Also, CDC advisory committee withdraws preferred status for AstraZeneca’s FluMist in children and adds Merck’s Gardasil 9 to recommendations for HPV vaccination.
You may also be interested in...
Promotion strategy likely to remain same after nine-valent HPV vaccine wins FDA approval; Merck may need help from the CDC to overcome cultural barriers to adoption.
Dosing is capped under emergency use authorizations, but studies show reduced antibody response following primary vaccination series in individuals with compromised immune systems; although BLA approval could allow for off-label prescribing, government officials are exploring other regulatory options for earlier access, including through a study.
In journal article, leaders from academia, industry, NCI and FDA propose building upon pandemic-necessitated flexibilities in clinical research, including making it easier for trial participants to access investigational drugs in their own communities and reduced reporting of uninformative adverse events.